MS4A superfamily molecules in tumors, Alzheimer's and autoimmune diseases

Xuejiao Luo1, Bin Luo2, Lei Fei2

  • 1Department of Dermatology, The Affiliated Hospital of the Non-Commissioned Officer (NCO) School, The Army Medical University, Shijiazhuang, Hebei, China.

Frontiers in Immunology
|December 24, 2024
PubMed

Insights

The MS4A superfamily, a group of membrane-spanning proteins, plays key roles in immune cell function and disease pathogenesis. Research highlights their potential as biomarkers and therapeutic targets for cancer and autoimmune diseases.

Area of Science:

  • Immunology and Molecular Biology
  • Cellular Signaling and Ion Transport

Background:

  • The MS4A (membrane-spanning 4-domain, subfamily A) superfamily comprises tetraspanin proteins with diverse roles in immune cells.
  • Eighteen MS4A members are identified in humans, with distinct expression patterns on immune cells like B cells, macrophages, and T cells.

Purpose of the Study:

  • To review recent advancements in understanding the MS4A superfamily's molecular mechanisms.
  • To elucidate the role of MS4A proteins in the pathogenesis of cancer, Alzheimer's disease, and autoimmune diseases.
  • To highlight the potential of MS4A members as biomarkers and therapeutic targets.

Main Methods:

  • Review of preclinical animal models and human genetic studies.
  • Analysis of molecular mechanisms underlying MS4A protein function.
  • Focus on MS4A's involvement in tumor progression, Alzheimer's disease, and autoimmune disorders.

Main Results:

  • MS4A proteins function as calcium ion channels and molecular chaperones.
  • They interact with immune receptors (PRRs, IgRs) to form signaling complexes and modulate cellular activity.
  • Evidence links MS4A superfamily to critical roles in cancer, infection, allergies, neurodegenerative, and autoimmune diseases.

Conclusions:

  • The MS4A superfamily is implicated in the pathogenesis of various significant diseases.
  • Further research into MS4A molecules can identify them as valuable biomarkers and therapeutic targets.
  • Understanding MS4A's role is crucial for developing novel treatment strategies for complex diseases.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
313
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
125
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K